Number of metabolic syndrome traits adds little to prediction of major adverse liver outcomes on top of FIB-4 in patients with type 2 diabetes

Number of metabolic syndrome traits adds little to prediction of major adverse liver outcomes on top of FIB-4 in patients with type 2 diabetes

Objective: Guidelines recommend use of the FIB-4 score to assess risk of advanced fibrosis in all patients with type 2 diabetes. It remains uncertain if there is an additional value to add information on number of metabolic syndrome (MetS) traits to FIB-4 to improve risk prediction of major adverse...

Full description

Saved in:
Bibliographic Details
Main Authors: Emilie Toresson Grip, Ying Shang, Helena Skröder, Angelo Modica, Oskar Ström, Fady Ntanios, Soffia Gudbjörnsdottir, Hannes Hagström
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Diabetes Epidemiology and Management
Subjects:
Fibrosis
Liver disease
Metabolic syndrome
Sweden
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S2666970625000241
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items